COR
NYSE · Health Care
Cencora Inc
$261.08
+5.42 (+2.12%)
Financial Highlights (FY 2026)
Revenue
313.56B
Net Income
1.52B
Gross Margin
3.5%
Profit Margin
0.5%
Rev Growth
+10.4%
D/E Ratio
5.08
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 3.5% | 3.5% | 43.8% | 43.8% |
| Operating Margin | 0.8% | 0.7% | 8.0% | 6.8% |
| Profit Margin | 0.5% | 0.5% | 5.6% | 6.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 313.56B | 283.95B | 64.56B | 50.79B |
| Gross Profit | 11.01B | 9.97B | 28.29B | 22.26B |
| Operating Income | 2.57B | 2.10B | 5.17B | 3.44B |
| Net Income | 1.52B | 1.24B | 3.64B | 3.39B |
| Gross Margin | 3.5% | 3.5% | 43.8% | 43.8% |
| Operating Margin | 0.8% | 0.7% | 8.0% | 6.8% |
| Profit Margin | 0.5% | 0.5% | 5.6% | 6.7% |
| Rev Growth | +10.4% | +10.4% | +21.6% | +22.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 20.78B | 20.78B | 3.76B | 4.55B |
| Total Equity | 4.09B | 4.09B | 26.18B | 25.95B |
| D/E Ratio | 5.08 | 5.08 | 0.14 | 0.18 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.52B | 3.03B | 6.65B | 4.98B |
| Free Cash Flow | — | — | 4.33B | 3.13B |